National Research (National Research) Days Sales Outstanding : 32.23 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is National Research Days Sales Outstanding?

National Research's average Accounts Receivable for the three months ended in Dec. 2023 was $13.4 Mil. National Research's Revenue for the three months ended in Dec. 2023 was $38.0 Mil. Hence, National Research's Days Sales Outstanding for the three months ended in Dec. 2023 was 32.23.

The historical rank and industry rank for National Research's Days Sales Outstanding or its related term are showing as below:

NRC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.96 Med: 34.3 Max: 40.76
Current: 33.12

During the past 13 years, National Research's highest Days Sales Outstanding was 40.76. The lowest was 31.96. And the median was 34.30.

NRC's Days Sales Outstanding is ranked better than
65.78% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 45.97 vs NRC: 33.12

National Research's Days Sales Outstanding declined from Dec. 2022 (35.69) to Dec. 2023 (32.23).

National Research Days Sales Outstanding Historical Data

The historical data trend for National Research's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Days Sales Outstanding Chart

National Research Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

33.60

35.00

34.11

33.94

32.97

National Research Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															35.69	35.88	32.94	31.69	32.23

Competitive Comparison of National Research's Days Sales Outstanding

For the Health Information Services subindustry, National Research's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

National Research's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where National Research's Days Sales Outstanding falls into.

National Research Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

National Research's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (14.461	+	12.378)	/	2 )	/	148.58	*	365
=	13.4195					/	148.58	*	365
=	32.97

National Research's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (14.467	+	12.378)	/	2 )	/	38.001	*	365 / 4
=	13.4225					/	38.001	*	365 / 4
=	32.23

National Research (NAS:NRC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

National Research Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of National Research's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

National Research (National Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1245 Q Street, Lincoln, NE, USA, 68508

Website

https://www.nrchealth.com

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.

Executives

Amandla Mk Trust	10 percent owner	C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust	10 percent owner	709 PIER 2, LINCOLN NE 68528
Parul Bhandari	director	1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Stephen H Lockhart	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Penny Ann Wheeler	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch	officer: Vice President and COO
Kevin R Karas	officer: SVP Finance, CFO, Treas & Secy	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009	10 percent owner	C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin	director	6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy	officer: Chief Growth Officer	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson	officer: President	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly	director	P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry	director	P.O. BOX 103115, DENVER CO 80250
Michael Hays	director, 10 percent owner, officer: President and CEO	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508